DENTSPLY International Enters a Joint Development Agreement to Utilize Regeneration Therapy for Treatment
17 May 2005
DENTSPLY International Inc. (NASDAQ:XRAY - News) today announced that it has entered into a joint development agreement with Two Cells Co. Ltd. (based in Hiroshima, Japan) regarding regeneration therapy utilizing neurotrophin (BDNF) for periodontal disease. As part of this agreement, Two Cells and Professor Hidemi Kurihara (Department of Periodontal Medicine, Division of Frontier Medical Science, Hiroshima University Graduate School of Biomedical Sciences) have granted DENTSPLY a worldwide license for this exciting technology. For its part, DENTSPLY will provide development funding to Two Cells. DENTSPLY, through its Office of Advanced Technology, continues to pursue outside technologies such as this, that may provide opportunities for future, innovative solutions to dentistry.
Mr. Gary Kunkle, DENTSPLY's Chairman and Chief Executive Officer, stated, "Our Office of Advanced Technology continues to identify exciting new technologies which will be used to advance the future of dentistry. This license agreement is based on an international patent application titled 'Remedy and Therapeutic Method for Periodontal Diseases and Pulpal Diseases' submitted by Professor Hidemi Kurihara of Hiroshima University and the University's venture company, Two Cells Co. Ltd. To date, this applied research into periodontal therapy using BDNF is unprecedented worldwide and its potential application in periodontal regeneration therapy would provide a significant improvement in the treatment of this disease."
DENTSPLY designs, develops, manufactures and markets a broad range of products for the dental market. The Company believes that it is the world's leading manufacturer and distributor of dental prosthetics, precious metal dental alloys, dental ceramics, endodontic instruments and materials, prophylaxis paste, dental sealants, ultrasonic scalers, and crown and bridge materials; the leading United States manufacturer and distributor of dental x-ray equipment, dental handpieces, intraoral cameras, dental x-ray film holders, film mounts and bone substitute/grafting materials; and a leading worldwide manufacturer or distributor of dental injectible anesthetics, impression materials, orthodontic appliances, dental cutting instruments and dental implants. The Company distributes its dental products in over 120 countries under some of the most well-established brand names in the industry.
DENTSPLY is committed to the development of innovative, high quality, cost-effective new products for the dental market.
This press release contains forward-looking statements regarding possible future events. Actual events or results may differ materially from the descriptions set forth herein as a result of certain risk factors. These risk factors include without limitation; the ability to develop commercially acceptable products which incorporate the technology, the continued strength of dental markets, the timing, success and market reception for new products, and changes in the general economic environment that could affect the dental business.
--------------------------------------------------------------------------------
Contact:
DENTSPLY International Inc.
William R. Jellison, 717-849-4243
--------------------------------------------------------------------------------
Source: DENTSPLY International Inc.
Source: Business Wire
All trademarks and copyrighted information contained herein are the property of their respective owners.
Related Articles
|
